A potential novel strategy, inhibition of vasopressin-induced VEGF secretion by relcovaptan, for decreasing the incidence of ovarian hyperstimulation syndrome in the hyperstimulated rat model

Cenksoy C., Cenksoy P., ERDEM O. A., Sancak B., Gursoy R.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, vol.174, pp.86-90, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 174
  • Publication Date: 2014
  • Doi Number: 10.1016/j.ejogrb.2013.12.001
  • Journal Name: EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.86-90
  • Keywords: OHSS, Prevention, VEGF, V1a receptor antagonist, Relcovaptan, ENDOTHELIAL GROWTH-FACTOR, SMOOTH-MUSCLE-CELLS, HORMONE AGONIST, CAPILLARY-PERMEABILITY, VASCULAR-PERMEABILITY, MOLECULAR-CLONING, EXPRESSION, RECEPTOR, PREVENTION, RISK
  • Bezmialem Vakıf University Affiliated: No

Abstract

Objective: To investigate the effects of VIA receptor antagonist through inhibition of vasopressin-induced, VEGF secretion in an experimental model.